News & Articles

Atomwise provides rapid and cost-effective compound screening to address pharmaceutical R&D productivity

Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva

A University of Bern international research team has succeeded in developing an electrocatalyst for hydrogen fuel cells

Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%

First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination

Supports cross-functional teams of chemists and biologists developing non-natural, chemically modified therapeutics for drug discovery

Researchers at the University of Bern have now discovered which genes play an important role in the response to radiation therapy

A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK as early as autumn, thanks to a £1.9million award from the UK government

The overall goal is to continue to detect and discover critical components in the overall cellular response to COVID-19

QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research

analytica gets a digital extension

Across all populations, BNT162b2 administration was well tolerated with mild to moderate fever in fewer than 20% of the participants

The test outperforms other molecular tests with a low detection limit of 15 GEC/reaction (250 GEC/ml of sample) and a robust control system